Latest News of INDT
Windtree Therapeutics Heart Failure Drug Candidate Improves Systolic Blood Pressure
By Yahoo! Finance |
5 days ago
Windtree Therapeutics announced positive Phase 2b results for istaroxime in treating cardiogenic shock. The study showed improvement in blood pressure and cardiac function over 96 hours, with promisin...
WINT Stock Price | Windtree Therapeutics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
By MarketWatch |
2 months ago
Windtree Therapeutics, Inc. is a biopharmaceutical company focusing on developing innovative treatments for acute cardiovascular and pulmonary diseases. Founded in 1992, it aims to address unmet medic...
Lindt's 2023 profit lifted by price hikes as chocolate market slows
By Reuters |
6 months ago
(Reuters) -Lindt & Spruengli reported a rise in annual profit on Tuesday as the Swiss chocolate maker managed to pass on higher ingredients costs to customers while maintaining volumes amid a broa...
-
Lindt 2023 profit rises on price hikes amid chocolate market slowdown
By Reuters | 6 months ago(Reuters) -Lindt & Spruengli reported higher 2023 profit on Tuesday as the Swiss chocolate maker managed to pass on increasing raw material costs to customers amid a slowdown in the global chocola...
-
Lindt full-year profit rises on price increases
By Reuters | 6 months ago(Reuters) - Swiss chocolate maker Lindt & Spruengli said on Tuesday its 2023 profit rose, as it increased prices in a challenging year that saw the price of cocoa soar. Net income rose 17.9% t...